Results 161 to 170 of about 51,268 (235)

Corrigendum to "Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium". [PDF]

Biomed Res Int, 2019
Hamelmann E.
europepmc   +1 more source

Revefenacin, a Long-Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo- and Positive-Controlled Thorough QT Study. [PDF]

Clin Pharmacol Drug Dev, 2020
Borin MT, Barnes CN, Darpo B, Pendyala S, Xue H, Bourdet DL.   +5 more
europepmc   +1 more source

Therapeutic effect of long-acting muscarinic antagonist for treating uncontrolled asthma assessed using impulse oscillometry. [PDF]

Respir Res
Sugawara H, Saito A, Yokoyama S, Chiba H.   +3 more
europepmc   +1 more source

Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers. [PDF]

Int J Chron Obstruct Pulmon Dis, 2020
Singer D, Bengtson LGS, Elliott C, Buikema AR, Franchino-Elder J.   +4 more
europepmc   +1 more source

Alterations in histamine responses between juvenile and adult urinary bladder urothelium, lamina propria and detrusor tissues [PDF]

, 2020
Chess-Williams, Russ, Moro, Christian, Stromberga, Zane   +2 more
core   +1 more source

Rationale and Design of an Exploratory, Randomized, Open-Label, Multicenter Clinical Trial to Investigate the Efficacy of Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist on Heart Failure Complicated by Chronic Obstructive Pulmonary Disease (COPD-HF Trial). [PDF]

Circ Rep
Hayashi H, Ito S, Fukuda H, Sata M, Abe Y, Fujimoto K, Fukuda D, Hanajima Y, Horii M, Ikehara N, Inoko M, Izumi C, Izumiya Y, Nakayama T, Sozu T, Toyoda S, Watanabe M, Yokoi M, Kitakaze M.   +18 more
europepmc   +1 more source

Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan. [PDF]

Int J Chron Obstruct Pulmon Dis, 2018
Yamada H, Hida N, Hizawa N.
europepmc   +1 more source

The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro. [PDF]

Respir Res
Matera MG, Rinaldi B, Calabrese C, Belardo C, Calzetta L, Cazzola M, Page C.   +6 more
europepmc   +1 more source

Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium. [PDF]

Biomed Res Int, 2018
Hamelmann E.
europepmc   +1 more source

Long-acting muscarinic antagonist and long-acting β₂-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative review. [PDF]

Ther Adv Respir Dis
Buhl R, Miravitlles M, Anzueto A, Brunton S.   +3 more
europepmc   +1 more source